Granulocyte-colony stimulating factors (G-CSFs) reduce the risk of febrile neutropenia in patients with cancer. This study evaluates the clinical and nonclinical value associated with G-CSFs.
Chelsey Kamson, BS
Advertisement
Articles by Chelsey Kamson, BS
Advertisement
Latest Updated Articles
- Estimating the Social Value of G-CSF Therapies in the United States
Published: October 10th 2016 | Updated:
Advertisement
Advertisement
